CSIMarket
 


Foamix Pharmaceuticals Ltd   (FOMX)
Other Ticker:  
 

Foamix Pharmaceuticals Ltd 's Working Capital Ratio

FOMX's quarterly Working Capital Ratio and Current Assets, Current Liabilities growth


In the wake of the increase in Current Liabilities in the forth quarter 2019, Working Capital Ratio fell to 2.61 a new company low.

Within Legal Cannabis industry 2 other companies have achieved higher Working Capital Ratio than Foamix Pharmaceuticals Ltd in forth quarter 2019. While Working Capital Ratio total ranking has improved so far during the IV Quarter 2019 to 1720, from total ranking in the third quarter 2019 at 1729.

Explain Working Capital Ratio
How much in Current Assets FOMX´s has?
What is the value of FOMX´s Current Liabilities?


FOMX Working Capital Ratio (Dec 31 2019)
IV. Quarter
(Sep 30 2019)
III. Quarter
(Jun 30 2019)
II. Quarter
(Mar 31 2019)
I. Quarter
(Dec 31 2018)
IV. Quarter
Y / Y Current Liabilities Change 170.66 % 42.01 % -8.83 % -16.07 % 1.59 %
Y / Y Current Assets Change -24.47 % -31.71 % 27.7 % 73.13 % 45.56 %
Working Capital Ratio MRQ 2.61 5.72 5.09 9.03 9.34
FOMX's Total Ranking # 1720 # 1729 # 810 # 452 # 177
Seq. Current Liabilities Change 119.34 % -5.16 % 49.49 % -12.97 % 15.08 %
Seq. Current Assets Change -0.15 % 6.71 % -15.8 % -15.81 % -9.72 %



Working Capital Ratio forth quarter 2019 Company Ranking
Within: No.
Legal Cannabis Industry # 3
Consumer Non Cyclical Sector # 56
Overall Market # 1720


Working Capital Ratio Statistics
High Average Low
23.29 9.48 2.61
(Jun 30 2016)   (Dec 31 2019)




Financial Statements
Foamix Pharmaceuticals Ltd 's Current Liabilities $ 29 Millions Visit FOMX's Balance sheet
Foamix Pharmaceuticals Ltd 's Current Assets $ 76 Millions Visit FOMX's Balance sheet
Source of FOMX's Sales Visit FOMX's Sales by Geography


Cumulative Foamix Pharmaceuticals Ltd 's Working Capital Ratio

FOMX's Working Capital Ratio for the trailling 12 Months

FOMX Working Capital Ratio

(Dec 31 2019)
IV. Quarter
(Sep 30 2019)
III. Quarter
(Jun 30 2019)
II. Quarter
(Mar 31 2019)
I. Quarter
(Dec 31 2018)
IV. Quarter
Y / Y Current Liabilities TTM Growth 170.66 % 42.01 % -8.83 % -16.07 % 1.59 %
Y / Y Current Assets TTM Growth -24.47 % -31.71 % 27.7 % 73.13 % 45.56 %
Working Capital Ratio TTM 4.68 7.01 8.45 7.85 6.79
Total Ranking TTM # 1488 # 5025 # 779 # 5006 # 5029
Seq. Current Liabilities TTM Growth 119.34 % -5.16 % 49.49 % -12.97 % 15.08 %
Seq. Current Assets TTM Growth -0.15 % 6.71 % -15.8 % -15.81 % -9.72 %


On the trailing twelve months basis Due to in Current Liabilities in the IV Quarter 2019 to $29.33 millions, cumulative Working Capital Ratio decreased to 4.68 below the Foamix Pharmaceuticals Ltd average Working Capital Ratio.
Working Capital Ratio is the average cumulative value over the last four quarters.

Among companies operating within Legal Cannabis industry 2 other companies have achieved higher Working Capital Ratio than Foamix Pharmaceuticals Ltd . While Working Capital Ratio overall ranking has improved so far to 1488, from total ranking during the twelve months ending third quarter 2019 at 5025.

Explain Working Capital Ratio
How much in Current Assets FOMX´s has?
What is the value of FOMX´s Current Liabilities?

TTM Working Capital Ratio Company Ranking
Within: No.
Within the Legal Cannabis Industry # 3
Consumer Non Cyclical Sector # 53
Within the Market # 1488


trailing twelve months Working Capital Ratio Statistics
High Average Low
15.08 8.44 4.68
(Jun 30 2016)   (Dec 31 2019)




Companies with similar Working Capital Ratio in the quarter ending Dec 31 2019, within Legal Cannabis Industry Working Capital RatioDec 31 2019 MRQ Current AssetsDec 31 2019 MRQ Current Liabilities
Natural Alternatives International Inc  6.12 $ 68.522  Millions$ 11.202  Millions
Mediwound Ltd   3.43 $ 35.622  Millions$ 10.373  Millions
Tilray Brands Inc   2.80 $ 259.027  Millions$ 92.427  Millions
Foamix Pharmaceuticals Ltd   2.61 $ 76.414  Millions$ 29.326  Millions
Usana Health Sciences Inc   2.42 $ 329.279  Millions$ 136.098  Millions
Chromadex Corporation  2.23 $ 33.518  Millions$ 15.063  Millions
Cyanotech Corp  2.10 $ 14.820  Millions$ 7.059  Millions
Fitlife Brands Inc   2.06 $ 5.711  Millions$ 2.776  Millions
Pure Harvest Corporate Group Inc   1.43 $ 1.839  Millions$ 1.290  Millions
Mannatech Incorporated  1.42 $ 41.029  Millions$ 28.892  Millions
Synergy Chc Corp   1.08 $ 5.047  Millions$ 4.682  Millions
Panacea Life Sciences Holdings Inc   1.04 $ 4.360  Millions$ 4.191  Millions
Quanta Inc.  0.89 $ 0.625  Millions$ 0.705  Millions
Tauriga Sciences Inc   0.84 $ 0.649  Millions$ 0.770  Millions
Charlie s Holdings Inc   0.83 $ 5.611  Millions$ 6.751  Millions
Healthy Extracts Inc   0.75 $ 3.241  Millions$ 4.315  Millions
Sndl Inc   0.64 $ 132.225  Millions$ 206.242  Millions

Date modified: 2023-03-25T00:22:20+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com